{"id":"https://openalex.org/W2887772017","doi":"https://doi.org/10.1158/1535-7163.targ-17-a146","title":"Abstract A146: Stromal neuregulin-1 modulates the response to MEK inhibitors in WT BRAF/WT NRAS (WT/WT) melanomas","display_name":"Abstract A146: Stromal neuregulin-1 modulates the response to MEK inhibitors in WT BRAF/WT NRAS (WT/WT) melanomas","publication_year":2018,"publication_date":"2018-01-01","ids":{"openalex":"https://openalex.org/W2887772017","doi":"https://doi.org/10.1158/1535-7163.targ-17-a146","mag":"2887772017"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.targ-17-a146","doi":"https://doi.org/10.1158/1535-7163.targ-17-a146","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-17-a146","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008451208","display_name":"Claudia Capparelli","orcid":"https://orcid.org/0000-0001-9834-8539","observed_orcids":["https://orcid.org/0000-0001-9834-8539"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]},{"id":"https://openalex.org/I4210106595","display_name":"Sidney Kimmel Cancer Center","ror":"https://ror.org/010h6g454","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210106595"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Claudia Capparelli","raw_affiliation_strings":["1Thomas Jefferson Univ. Kimmel Cancer Ctr., Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Thomas Jefferson Univ. Kimmel Cancer Ctr., Philadelphia, PA;","institution_ids":["https://openalex.org/I149251103","https://openalex.org/I4210106595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085398803","display_name":"Timothy J. Purwin","orcid":"https://orcid.org/0000-0002-7053-8039","observed_orcids":["https://orcid.org/0000-0002-7053-8039"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]},{"id":"https://openalex.org/I4210106595","display_name":"Sidney Kimmel Cancer Center","ror":"https://ror.org/010h6g454","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210106595"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy J. Purwin","raw_affiliation_strings":["1Thomas Jefferson Univ. Kimmel Cancer Ctr., Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Thomas Jefferson Univ. Kimmel Cancer Ctr., Philadelphia, PA;","institution_ids":["https://openalex.org/I149251103","https://openalex.org/I4210106595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085086811","display_name":"Shea A. Heilman","orcid":"https://orcid.org/0000-0003-4337-5446","observed_orcids":["https://orcid.org/0000-0003-4337-5446"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]},{"id":"https://openalex.org/I4210106595","display_name":"Sidney Kimmel Cancer Center","ror":"https://ror.org/010h6g454","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210106595"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shea Heilman","raw_affiliation_strings":["1Thomas Jefferson Univ. Kimmel Cancer Ctr., Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Thomas Jefferson Univ. Kimmel Cancer Ctr., Philadelphia, PA;","institution_ids":["https://openalex.org/I149251103","https://openalex.org/I4210106595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022471130","display_name":"Inna Chervoneva","orcid":"https://orcid.org/0000-0002-9104-4505","observed_orcids":["https://orcid.org/0000-0002-9104-4505"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]},{"id":"https://openalex.org/I4210106595","display_name":"Sidney Kimmel Cancer Center","ror":"https://ror.org/010h6g454","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210106595"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Inna Chervoneva","raw_affiliation_strings":["1Thomas Jefferson Univ. Kimmel Cancer Ctr., Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Thomas Jefferson Univ. Kimmel Cancer Ctr., Philadelphia, PA;","institution_ids":["https://openalex.org/I149251103","https://openalex.org/I4210106595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048327749","display_name":"Michael A. Davies","orcid":"https://orcid.org/0000-0002-0977-0912","observed_orcids":["https://orcid.org/0000-0002-0977-0912"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael A. Davies","raw_affiliation_strings":["2University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081648218","display_name":"Jeffrey E. Gershenwald","orcid":"https://orcid.org/0000-0003-4519-5369","observed_orcids":["https://orcid.org/0000-0003-4519-5369"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]},{"id":"https://openalex.org/I4210106595","display_name":"Sidney Kimmel Cancer Center","ror":"https://ror.org/010h6g454","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210106595"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey\u00a0 E. Gershenwald","raw_affiliation_strings":["1Thomas Jefferson Univ. Kimmel Cancer Ctr., Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Thomas Jefferson Univ. Kimmel Cancer Ctr., Philadelphia, PA;","institution_ids":["https://openalex.org/I149251103","https://openalex.org/I4210106595"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062746446","display_name":"Andrew E. Aplin","orcid":"https://orcid.org/0000-0002-2734-3244","observed_orcids":["https://orcid.org/0000-0002-2734-3244"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]},{"id":"https://openalex.org/I4210106595","display_name":"Sidney Kimmel Cancer Center","ror":"https://ror.org/010h6g454","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210106595"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew E. Aplin","raw_affiliation_strings":["1Thomas Jefferson Univ. Kimmel Cancer Ctr., Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Thomas Jefferson Univ. Kimmel Cancer Ctr., Philadelphia, PA;","institution_ids":["https://openalex.org/I149251103","https://openalex.org/I4210106595"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":"1_Supplement","first_page":"A146","last_page":"A146"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11173","display_name":"Neurofibromatosis and Schwannoma Cases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuregulin-1","display_name":"neuregulin-1","score":0.9860000014305115},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.921999990940094},{"id":"https://openalex.org/keywords/trametinib","display_name":"trametinib","score":0.828000009059906},{"id":"https://openalex.org/keywords/braf-wild-type","display_name":"BRAF wild-type","score":0.7580000162124634},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8140000104904175},{"id":"https://openalex.org/keywords/cancer-associated-fibroblasts","display_name":"cancer-associated fibroblasts","score":0.9769999980926514},{"id":"https://openalex.org/keywords/her3","display_name":"HER3","score":0.7710000276565552},{"id":"https://openalex.org/keywords/erbb2","display_name":"ERBB2","score":0.996999979019165},{"id":"https://openalex.org/keywords/mek-erk-signaling","display_name":"MEK/ERK signaling","score":0.7919999957084656},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.9449999928474426},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7049999833106995},{"id":"https://openalex.org/keywords/stromal-fibroblasts","display_name":"stromal fibroblasts","score":0.6790000200271606}],"concepts":[{"id":"https://openalex.org/C21790070","wikidata":"https://www.wikidata.org/wiki/Q18030215","display_name":"Neuroblastoma RAS viral oncogene homolog","level":5,"score":0.7681928873062134},{"id":"https://openalex.org/C2778560701","wikidata":"https://www.wikidata.org/wiki/Q14914188","display_name":"Neuregulin 1","level":3,"score":0.6725283265113831},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6580259203910828},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6463316082954407},{"id":"https://openalex.org/C115456853","wikidata":"https://www.wikidata.org/wiki/Q17917132","display_name":"ERBB3","level":4,"score":0.639779806137085},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6082443594932556},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.5155506134033203},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.4911651313304901},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4840209186077118},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.4341503977775574},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3867451250553131},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3416050374507904},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.34000396728515625},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.31246447563171387},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2562141418457031},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2363327145576477},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.2127053439617157},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17576757073402405},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.07416704297065735},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.targ-17-a146","doi":"https://doi.org/10.1158/1535-7163.targ-17-a146","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-17-a146","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7062111305","https://openalex.org/W2885459183","https://openalex.org/W2562718573","https://openalex.org/W1972304383","https://openalex.org/W2127258026","https://openalex.org/W1909910581","https://openalex.org/W2561067358","https://openalex.org/W2315283981","https://openalex.org/W7098267238","https://openalex.org/W2104581309"],"abstract_inverted_index":{"Abstract":[0],"MEK-ERK1/2":[1],"signaling":[2,120],"is":[3],"elevated":[4],"in":[5,33,66,100,109,121,141,151,201],"the":[6,47,57,67,101,133,160,166,196,211],"majority":[7],"of":[8,59,69,97,104,136,162,168,210],"melanomas.":[9],"While":[10],"MEK":[11,122,199],"inhibitors":[12,200],"(MEKi)":[13],"are":[14,38],"FDA-approved":[15],"for":[16,41,159],"mutant":[17,26],"BRAF":[18,42],"melanoma,":[19],"and":[20,43,89,111,115,128,138,143,170,217],"have":[21,29],"some":[22],"activity":[23,32],"against":[24],"NRAS":[25,44,204],"tumors,":[27],"they":[28],"shown":[30],"little":[31],"patients":[34],"with":[35,145,165],"melanomas":[36,164,206],"that":[37],"wild":[39],"type":[40],"(WT/WT).":[45],"Since":[46],"tumor":[48],"microenvironment":[49],"(TME)":[50],"often":[51],"regulates":[52],"drug":[53],"resistance,":[54],"we":[55],"tested":[56],"effects":[58,103,135],"growth":[60,65,81,150],"factors":[61],"on":[62],"WT/WT":[63,75,124,163],"melanoma":[64,77,125],"presence":[68],"MEKi.":[70],"Neuregulin-1":[71],"(NRG1)":[72],"protected":[73],"patient-derived":[74],"human":[76],"cell":[78],"lines":[79],"from":[80],"inhibition":[82],"mediated":[83],"by":[84],"trametinib":[85],"(MEKi).":[86],"Phospho-proteomic":[87],"analysis":[88],"clinical":[90],"grade":[91],"neutralizing":[92,130],"antibodies":[93,131],"implicated":[94],"adaptive":[95],"activation":[96],"ErbB3/ErbB2":[98,119],"complexes":[99],"protective":[102,134],"NRG1.":[105],"NRG1":[106,140],"was":[107],"detected":[108],"fibroblasts":[110,113],"cancer-associated":[112],"(CAF),":[114],"CAF-conditioned":[116],"medium":[117],"activated":[118],"inhibited":[123],"cells.":[126],"ErbB3":[127],"ErbB2":[129],"blocked":[132],"fibroblast-":[137],"CAF-derived":[139],"vitro":[142],"cooperated":[144],"MEKi":[146,169],"to":[147,198],"delay":[148],"xenograft":[149],"vivo.":[152],"Together":[153],"our":[154],"results":[155],"provide":[156],"a":[157],"rationale":[158],"treatment":[161],"combination":[167],"anti-ErbB3/ErbB2":[171],"antibodies.":[172],"Citation":[173],"Format:":[174],"Claudia":[175],"Capparelli,":[176],"Timothy":[177],"J.":[178],"Purwin,":[179],"Shea":[180],"Heilman,":[181],"Inna":[182],"Chervoneva,":[183],"Michael":[184],"A.":[185],"Davies,":[186],"Jeffrey":[187],"E.":[188,191],"Gershenwald,":[189],"Andrew":[190],"Aplin.":[192],"Stromal":[193],"neuregulin-1":[194],"modulates":[195],"response":[197],"WT":[202],"BRAF/WT":[203],"(WT/WT)":[205],"[abstract].":[207],"In:":[208],"Proceedings":[209],"AACR-NCI-EORTC":[212],"International":[213],"Conference:":[214],"Molecular":[215],"Targets":[216],"Cancer":[218,229],"Therapeutics;":[219],"2017":[220],"Oct":[221],"26-30;":[222],"Philadelphia,":[223],"PA.":[224],"Philadelphia":[225],"(PA):":[226],"AACR;":[227],"Mol":[228],"Ther":[230],"2018;17(1":[231],"Suppl):Abstract":[232],"nr":[233],"A146.":[234]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-08-22T00:00:00"}